应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
VCEL Vericel Corporation
盘前交易 10-02 05:07:11 EDT
40.05
-2.20
-5.21%
最高
42.08
最低
39.66
成交量
56.34万
今开
41.90
昨收
42.25
日振幅
5.73%
总市值
19.64亿
流通市值
19.45亿
总股本
4,903万
成交额
2,271万
换手率
1.16%
流通股本
4,857万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Vericel Corporation盘中异动 股价大跌5.11%
市场透视 · 10-01 23:51
Vericel Corporation盘中异动 股价大跌5.11%
Vericel Corporation盘中异动 股价大涨5.16%报48.74美元
市场透视 · 09-19
Vericel Corporation盘中异动 股价大涨5.16%报48.74美元
BUZZ-Vericel和MediWound因美国食品和药物管理局扩大皮肤治疗批准范围而攀升
Reuters · 08-16
BUZZ-Vericel和MediWound因美国食品和药物管理局扩大皮肤治疗批准范围而攀升
Vericel Corporation2024财年第二财季实现净利润-4.68百万美元,同比增加6.77%
自选股智能写手 · 08-10
Vericel Corporation2024财年第二财季实现净利润-4.68百万美元,同比增加6.77%
HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由55.
智通财经 · 08-02
HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由55.
Vericel Corporation盘中异动 股价大跌8.95%报46.00美元
自选股智能写手 · 08-01
Vericel Corporation盘中异动 股价大跌8.95%报46.00美元
Vericel Corp 预计每股亏损 8 美分 - 财报前瞻
Reuters · 07-31
Vericel Corp 预计每股亏损 8 美分 - 财报前瞻
Vericel Corporation盘中异动 快速上涨5.04%
自选股智能写手 · 07-17
Vericel Corporation盘中异动 快速上涨5.04%
Truist Securities:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至57.
智通财经 · 07-16
Truist Securities:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至57.
Vericel Corporation盘中异动 快速拉升5.32%报47.87美元
自选股智能写手 · 07-11
Vericel Corporation盘中异动 快速拉升5.32%报47.87美元
Vericel Corporation盘中异动 大幅拉升5.42%报45.72美元
自选股智能写手 · 06-20
Vericel Corporation盘中异动 大幅拉升5.42%报45.72美元
Vericel Corporation2024财年第一财季实现净利润-3.86百万美元,同比增加48.53%
自选股智能写手 · 05-17
Vericel Corporation2024财年第一财季实现净利润-3.86百万美元,同比增加48.53%
HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至55.00美元。
智通财经 · 05-10
HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至55.00美元。
Vericel 公司报告截至三月份的季度业绩 - 收益摘要
Reuters · 05-08
Vericel 公司报告截至三月份的季度业绩 - 收益摘要
Vericel Corporation盘中异动 早盘股价大跌5.98%报46.56美元
自选股智能写手 · 05-08
Vericel Corporation盘中异动 早盘股价大跌5.98%报46.56美元
Vericel(VCEL.US):2024年Q1财报实现营收5128.1万美元,前值为4101.7万美元,预期值为4907万美元;
智通财经 · 05-08
Vericel(VCEL.US):2024年Q1财报实现营收5128.1万美元,前值为4101.7万美元,预期值为4907万美元;
Vericel Corporation盘中异动 快速上涨5.05%
自选股智能写手 · 05-08
Vericel Corporation盘中异动 快速上涨5.05%
Vericel Corporation盘中异动 股价大涨5.14%
自选股智能写手 · 05-02
Vericel Corporation盘中异动 股价大涨5.14%
Vericel Corporation盘中异动 股价大跌5.11%
自选股智能写手 · 04-19
Vericel Corporation盘中异动 股价大跌5.11%
柯利明正式宣布新身份:万达电影实际控制人
蓝鲸财经 · 04-18
柯利明正式宣布新身份:万达电影实际控制人
加载更多
公司概况
公司名称:
Vericel Corporation
所属市场:
NASDAQ
上市日期:
--
主营业务:
Vericel Corporation成立于1989年,是一家再生医学公司,专注于创新细胞疗法的开发,以修复或再生受损或患病组织。该公司正在开发治疗重症、慢性缺血性心脑血管疾病的特定病人的多细胞疗法。该公司认为ixmyelocel-T是一种多功能的疾病改善疗法,包括组织重建、免疫调节和促进血管生成。该公司专有的电池制造技术使多细胞疗法的制造成为可能,扩大成年病人的骨髓,直接输送到受损的组织。临床前和临床数据表明,ixmyelocel-T可能能安全有效地治疗重症、慢性缺血性心血管疾病,如严重肢体缺血(CLI)——最严重的外周动脉疾病(PAD),和扩张型心肌病(DCM )——心脏衰竭的第三大成因。
发行价格:
--
{"stockData":{"symbol":"VCEL","market":"US","secType":"STK","nameCN":"Vericel Corporation","latestPrice":40.05,"timestamp":1727812800000,"preClose":42.25,"halted":0,"volume":563397,"delay":0,"floatShares":48573767,"shares":49030175,"eps":0.006225,"marketStatus":"盘前交易","marketStatusCode":1,"change":-2.2,"latestTime":"10-02 05:07:11 EDT","open":41.9,"high":42.08,"low":39.66,"amount":22706506.471641,"amplitude":0.057278,"askPrice":57,"askSize":3,"bidPrice":33.19,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.006225,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1727875800000},"adr":0,"listingDate":855032400000,"adjPreClose":40.05,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":40.05,"preClose":40.05,"latestTime":"19:46 EDT","volume":14638,"amount":586214.5198,"timestamp":1727826409142},"volumeRatio":1.6874519282831286,"impliedVol":0.5081,"impliedVolPercentile":0.4024},"requestUrl":"/m/hq/s/VCEL","defaultTab":"news","newsList":[{"id":"2472305004","title":"Vericel Corporation盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472305004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472305004?lang=zh_cn&edition=full","pubTime":"2024-10-01 23:51","pubTimestamp":1727797909,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日23时51分,Vericel Corporation股票出现异动,股价快速下跌5.11%。截至发稿,该股报40.09美元/股,成交量12.1533万股,换手率0.25%,振幅4.52%。Vericel Corporation股票所在的生物技术行业中,整体跌幅为0.23%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001235149ab675439&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241001235149ab675439&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2468508208","title":"Vericel Corporation盘中异动 股价大涨5.16%报48.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508208?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:19","pubTimestamp":1726755565,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时19分,Vericel Corporation股票出现波动,股价大幅拉升5.16%。截至发稿,该股报48.74美元/股,成交量5.4483万股,换手率0.11%,振幅2.29%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为1.26%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221926a1db33d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919221926a1db33d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL","BK4139"],"gpt_icon":0},{"id":"2459288149","title":"BUZZ-Vericel和MediWound因美国食品和药物管理局扩大皮肤治疗批准范围而攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2459288149","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459288149?lang=zh_cn&edition=full","pubTime":"2024-08-16 04:59","pubTimestamp":1723755556,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 8月15日 - ** Vericel 股价上涨~2%,报47.05美元;MediWound 上涨~1.8%,报18.50美元;在盘后交易中** 疗法开发商 称,美国 FDA 批准 (link) 在烧伤儿童患者中使用 NexoBrid药物去除死皮 ** 这种酶制剂 最初于 2022 年获准用于成人治疗**MDWD开发了 NexoBrid,而VCEL拥有该疗法在北美的独家许可权。** 截至上次收盘,VCEL上涨29.6%,MDWD上涨78.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCEL","BUZZ","BK4007","MDWD","BK4139"],"gpt_icon":0},{"id":"2458804516","title":"Vericel Corporation2024财年第二财季实现净利润-4.68百万美元,同比增加6.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458804516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458804516?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:18","pubTimestamp":1723220320,"startTime":"0","endTime":"0","summary":"8月10日,Vericel Corporation公布财报,公告显示公司2024财年第二财季净利润为-4.68百万美元,同比增加6.77%;其中营业收入为52.66百万美元,同比增加14.68%,每股基本收益为-0.10美元。从资产负债表来看,Vericel Corporation总负债1.34亿美元,其中短期债务5.79百万美元,资产负债比为2.82,流动比率为0.05。机构评级:截至2024年8月10日,当前有8家机构对Vericel Corporation目标价做出预测,其中目标均价为56.62美元,其中最低目标价为54.00美元,最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100018459f1e1112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100018459f1e1112&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL"],"gpt_icon":0},{"id":"2456400621","title":"HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由55.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456400621","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456400621?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:17","pubTimestamp":1722601023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2456830435","title":"Vericel Corporation盘中异动 股价大跌8.95%报46.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456830435","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456830435?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:31","pubTimestamp":1722519092,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时31分,Vericel Corporation股票出现波动,股价快速下挫8.95%。截至发稿,该股报46.00美元/股,成交量1.2286万股,换手率0.03%,振幅5.01%。Vericel Corporation股票所在的生物技术行业中,整体跌幅为0.46%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012131329f05afa0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408012131329f05afa0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL","BK4139"],"gpt_icon":0},{"id":"2455496961","title":"Vericel Corp 预计每股亏损 8 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455496961","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455496961?lang=zh_cn&edition=full","pubTime":"2024-07-31 02:34","pubTimestamp":1722364464,"startTime":"0","endTime":"0","summary":" * Vericel公司 将于8月1日公布截至2024年6月30日的财报,预计季度收入将有所增长。* 根据LSEG的数据,7位分析师的平均预期显示,这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的4592万美元增长14.5%,达到5258.6万美元。* LSEG 分析师对 Vericel Corp 的平均预期是每股亏损 8 美分。* 华尔街对 Vericel Corp 的 12 个月目标价中值为 55.00 美元,高于其上一次收盘价 51.48 美元。7月30日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCEL"],"gpt_icon":0},{"id":"2452094424","title":"Vericel Corporation盘中异动 快速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452094424","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452094424?lang=zh_cn&edition=full","pubTime":"2024-07-17 03:36","pubTimestamp":1721158575,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日03时36分,Vericel Corporation股票出现异动,股价急速上涨5.04%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为0.34%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。消息层面,截至03时36分,Vericel Corporation股票正面舆情新闻比例50%。《BTIG维持Vericel买入评级,下调目标价至55美元》资讯为影响Vericel Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717033615941f786b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717033615941f786b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL","BK4139"],"gpt_icon":0},{"id":"2451138909","title":"Truist Securities:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由56.00美元调整至57.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451138909","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451138909?lang=zh_cn&edition=full","pubTime":"2024-07-16 22:04","pubTimestamp":1721138666,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VCEL","BK4139"],"gpt_icon":0},{"id":"2450369809","title":"Vericel Corporation盘中异动 快速拉升5.32%报47.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450369809","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450369809?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:14","pubTimestamp":1720707285,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时14分,Vericel Corporation股票出现波动,股价急速拉升5.32%。截至发稿,该股报47.87美元/股,成交量1.2888万股,换手率0.03%,振幅4.09%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为0.74%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711221445aef93ee6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711221445aef93ee6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2444124362","title":"Vericel Corporation盘中异动 大幅拉升5.42%报45.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444124362","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444124362?lang=zh_cn&edition=full","pubTime":"2024-06-20 21:48","pubTimestamp":1718891322,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日21时48分,Vericel Corporation股票出现异动,股价大幅拉升5.42%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为0.13%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。消息层面,截至21时48分,《TD Cowen首予Vericel买入评级,目标价55美元》资讯为影响Vericel Corporation的重要信息。根据TipRanks数据显示,该分析师近一年总胜率为50.5%,总平均回报率为6.2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214842941efd70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240620214842941efd70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL","BK4139"],"gpt_icon":0},{"id":"2436220607","title":"Vericel Corporation2024财年第一财季实现净利润-3.86百万美元,同比增加48.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436220607","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436220607?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:22","pubTimestamp":1715876578,"startTime":"0","endTime":"0","summary":"3月31日,Vericel Corporation公布财报,公告显示公司2024财年第一财季净利润为-3.86百万美元,同比增加48.53%;其中营业收入为51.28百万美元,同比增加25.01%,每股基本收益为-0.08美元。从资产负债表来看,Vericel Corporation总负债1.23亿美元,其中短期债务6.01百万美元,资产负债比为2.91,流动比率为0.06。机构评级:截至2024年3月31日,当前有6家机构对Vericel Corporation目标价做出预测,其中目标均价为55.50美元,其中最低目标价为53.00美元,最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170023058b0f8de7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170023058b0f8de7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL"],"gpt_icon":0},{"id":"2434004104","title":"HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434004104","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434004104?lang=zh_cn&edition=full","pubTime":"2024-05-10 03:15","pubTimestamp":1715282108,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:维持Vericel(VCEL.US)评级,由买入调整至买入评级, 目标价由53.00美元调整至55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051003151187e5f9ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051003151187e5f9ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL"],"gpt_icon":0},{"id":"2433727628","title":"Vericel 公司报告截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433727628","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433727628?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:40","pubTimestamp":1715179239,"startTime":"0","endTime":"0","summary":" * Vericel Corp 公布,在截至 3 月份的季度调整后每股亏损 8 美分,高于去年同期的每股-16 美分。六位分析师对该季度的平均预期是每股亏损 11 美分。华尔街预期为每股-17美分至-5美分。* Vericel 公司公布的本季度每股收益为亏损 8 美分。* 该公司的季度亏损额为 386 万美元。* Vericel Corp本季度股价下跌了4.8%,今年迄今为止上涨了39.1%。5月8日 - 预测变化 * 过去三个月,分析师的平均盈利预期下降了约 16.8%。华尔街对 Vericel Corp 的 12 个月目标价中位数为 55.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2433721485","title":"Vericel Corporation盘中异动 早盘股价大跌5.98%报46.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433721485","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433721485?lang=zh_cn&edition=full","pubTime":"2024-05-08 21:32","pubTimestamp":1715175162,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日21时32分,Vericel Corporation股票出现波动,股价快速下跌5.98%。截至发稿,该股报46.56美元/股,成交量6548股,换手率0.01%,振幅2.20%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为0.32%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821324287e096b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050821324287e096b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2433740357","title":"Vericel(VCEL.US):2024年Q1财报实现营收5128.1万美元,前值为4101.7万美元,预期值为4907万美元;","url":"https://stock-news.laohu8.com/highlight/detail?id=2433740357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433740357?lang=zh_cn&edition=full","pubTime":"2024-05-08 19:55","pubTimestamp":1715169346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2433254787","title":"Vericel Corporation盘中异动 快速上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433254787","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433254787?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:07","pubTimestamp":1715098021,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日00时07分,Vericel Corporation股票出现波动,股价快速上涨5.05%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为1.17%。其相关个股中,Lexaria Bioscience Corp C/Wts 14/01/2026 、Carmell Corp C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大,Clearmind Medicine Inc.、Allarity Therapeutics, Inc.、Tc Biopharm Plc较为活跃,换手率分别为1434.11%、218.50%、182.95%,振幅较大的相关个股有Avenue Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、珐博进,振幅分别为42.73%、41.69%、41.38%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050800070279264ef1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050800070279264ef1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2432635790","title":"Vericel Corporation盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432635790","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432635790?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:09","pubTimestamp":1714590563,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时09分,Vericel Corporation股票出现波动,股价急速拉升5.14%。Vericel Corporation股票所在的生物技术行业中,整体涨幅为2.46%。其相关个股中,Cytomx Therapeutics, Inc.、Dermata Therapeutics Inc C/Wts 、Bioatla, Inc.涨幅较大,Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃,换手率分别为1418.50%、1232.84%、270.61%,振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ,振幅分别为188.34%、99.53%、77.43%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203092487e853c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050203092487e853c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VCEL"],"gpt_icon":0},{"id":"2428542545","title":"Vericel Corporation盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428542545","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428542545?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:34","pubTimestamp":1713465291,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时34分,Vericel Corporation股票出现异动,股价急速下挫5.11%。Vericel Corporation股票所在的生物技术行业中,整体跌幅为0.69%。Vericel Corporation公司简介:Vericel Corp是一家全面一体化的商业化阶段的生物制药公司,专注于运动医学和严重烧伤护理市场的各种疗法。消息层面,截至02时34分,《Form 144 | Vericel高管拟出售1.75万股股份,价值约81.32万美元》资讯为影响Vericel Corporation的重要信息。此外,Colangelo Dominick自2024年1月17日起至今合共已减持该公司10.35万股股份,总价值约450.98万美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041902345287e81cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041902345287e81cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VCEL","BK4139"],"gpt_icon":0},{"id":"2428259057","title":"柯利明正式宣布新身份:万达电影实际控制人","url":"https://stock-news.laohu8.com/highlight/detail?id=2428259057","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2428259057?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:18","pubTimestamp":1713449895,"startTime":"0","endTime":"0","summary":"4月16日晚,万达文化及王健林将万达电影控股股东万达投资的21.2%股权转让给了柯利明旗下的儒意投资。至此,儒意投资累计受让了万达投资51%股权,柯利明拿下了国内最大的院线,正式成为万达电影的实际控制人。而对于此次交易的另一方柯利明而言,在拿下万达电影的控制权后,其也可以借助万达电影旗下近900家院线资产,打通了电影产业链上下游。2023年12月6日,万达电影官宣停牌,开始筹划控制权变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/230698","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["VCEL","BK1598","BK4139","BK1590","BK1516","BK1128","00136","BK1142"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vcel.com","stockEarnings":[{"period":"1week","weight":-0.1048},{"period":"1month","weight":-0.2246},{"period":"3month","weight":-0.1082},{"period":"6month","weight":-0.2057},{"period":"1year","weight":0.2067},{"period":"ytd","weight":0.1247}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0311},{"period":"6month","weight":0.1083},{"period":"1year","weight":0.3307},{"period":"ytd","weight":0.1963}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vericel Corporation成立于1989年,是一家再生医学公司,专注于创新细胞疗法的开发,以修复或再生受损或患病组织。该公司正在开发治疗重症、慢性缺血性心脑血管疾病的特定病人的多细胞疗法。该公司认为ixmyelocel-T是一种多功能的疾病改善疗法,包括组织重建、免疫调节和促进血管生成。该公司专有的电池制造技术使多细胞疗法的制造成为可能,扩大成年病人的骨髓,直接输送到受损的组织。临床前和临床数据表明,ixmyelocel-T可能能安全有效地治疗重症、慢性缺血性心血管疾病,如严重肢体缺血(CLI)——最严重的外周动脉疾病(PAD),和扩张型心肌病(DCM )——心脏衰竭的第三大成因。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.055623},{"month":2,"riseRate":0.8,"avgChangeRate":0.08202},{"month":3,"riseRate":0.5,"avgChangeRate":0.18166},{"month":4,"riseRate":0.4,"avgChangeRate":0.003371},{"month":5,"riseRate":0.4,"avgChangeRate":-0.01162},{"month":6,"riseRate":0.4,"avgChangeRate":-0.005243},{"month":7,"riseRate":0.7,"avgChangeRate":0.057946},{"month":8,"riseRate":0.4,"avgChangeRate":-0.003948},{"month":9,"riseRate":0.5,"avgChangeRate":0.042244},{"month":10,"riseRate":0.3,"avgChangeRate":-0.074205},{"month":11,"riseRate":0.666667,"avgChangeRate":0.109065},{"month":12,"riseRate":0.8,"avgChangeRate":0.100151}],"exchange":"NASDAQ","name":"Vericel Corporation","nameEN":"Vericel"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vericel Corporation(VCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vericel Corporation(VCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vericel Corporation,VCEL,Vericel Corporation股票,Vericel Corporation股票老虎,Vericel Corporation股票老虎国际,Vericel Corporation行情,Vericel Corporation股票行情,Vericel Corporation股价,Vericel Corporation股市,Vericel Corporation股票价格,Vericel Corporation股票交易,Vericel Corporation股票购买,Vericel Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vericel Corporation(VCEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vericel Corporation(VCEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}